[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100116446":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":10,"locations":24,"responsibleParty":142,"collaborators":10,"id":145,"slug":146,"hasResults":147,"nctId":148,"briefTitle":149,"officialTitle":150,"acronym":151,"eligibilityCriteria":152,"healthyVolunteers":147,"sex":153,"minAge":154,"maxAge":10,"enrollmentInfo":155,"targetDuration":10,"studyType":158,"phases":10,"briefSummary":159,"conditions":160,"keywords":162,"overallStatus":165,"whyStopped":10,"lastUpdateSubmitDate":166,"lastUpdatePostDateStruct":167,"startDateStruct":170,"completionDateStruct":172,"leadSponsor":174,"locationsCount":175},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"1",null,"patients being diagnosed as dyslipidemia but not receiving Crestor®",{"label":13,"type":10,"description":14,"interventionNames":10},"2","hypercholesterolemia or mixed dyslipidemia and have been initiated treatment with Crestor®",[16,20],{"name":17,"affiliation":18,"role":19},"Karen Atkin","Astrazeneca China R&D","STUDY_DIRECTOR",{"name":21,"affiliation":22,"role":23},"Zhu Junren","Fudan University","PRINCIPAL_INVESTIGATOR",[25,37,40,47,55,63,71,79,87,94,102,110,118,126,134],{"facility":26,"status":10,"city":27,"state":28,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":10},"Research Site","Beijing","Beijing Municipality","China","CN",{"type":32,"coordinates":33},"Point",[34,35],116.39723,39.9075,{"lat":35,"lon":34},{"facility":26,"status":10,"city":38,"state":39,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":10,"geoPoint":10,"contacts":10},"Chenzhen","Guangdong",{"facility":26,"status":10,"city":41,"state":39,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":42,"geoPoint":46,"contacts":10},"Guangzhou",{"type":32,"coordinates":43},[44,45],113.25,23.11667,{"lat":45,"lon":44},{"facility":26,"status":10,"city":48,"state":49,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":50,"geoPoint":54,"contacts":10},"Harbin","Heilongjiang",{"type":32,"coordinates":51},[52,53],126.65,45.75,{"lat":53,"lon":52},{"facility":26,"status":10,"city":56,"state":57,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":58,"geoPoint":62,"contacts":10},"Zhengzhou","Henan",{"type":32,"coordinates":59},[60,61],113.64861,34.75778,{"lat":61,"lon":60},{"facility":26,"status":10,"city":64,"state":65,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":66,"geoPoint":70,"contacts":10},"Nanjing","Jiangsu",{"type":32,"coordinates":67},[68,69],118.77778,32.06167,{"lat":69,"lon":68},{"facility":26,"status":10,"city":72,"state":73,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":74,"geoPoint":78,"contacts":10},"Shenyang","Liaoning",{"type":32,"coordinates":75},[76,77],123.43278,41.79222,{"lat":77,"lon":76},{"facility":26,"status":10,"city":80,"state":81,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":82,"geoPoint":86,"contacts":10},"Jinan","Shandong",{"type":32,"coordinates":83},[84,85],116.99722,36.66833,{"lat":85,"lon":84},{"facility":26,"status":10,"city":88,"state":81,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":89,"geoPoint":93,"contacts":10},"Qingdao",{"type":32,"coordinates":90},[91,92],120.38042,36.06488,{"lat":92,"lon":91},{"facility":26,"status":10,"city":95,"state":96,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":97,"geoPoint":101,"contacts":10},"Shanghai","Shanghai Municipality",{"type":32,"coordinates":98},[99,100],121.45806,31.22222,{"lat":100,"lon":99},{"facility":26,"status":10,"city":103,"state":104,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":105,"geoPoint":109,"contacts":10},"Xi’an","Shanxi",{"type":32,"coordinates":106},[107,108],113.52486,35.99785,{"lat":108,"lon":107},{"facility":26,"status":10,"city":111,"state":112,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":113,"geoPoint":117,"contacts":10},"Chengdu","Sichuan",{"type":32,"coordinates":114},[115,116],104.06667,30.66667,{"lat":116,"lon":115},{"facility":26,"status":10,"city":119,"state":120,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":121,"geoPoint":125,"contacts":10},"Tianjin","Tianjin Municipality",{"type":32,"coordinates":122},[123,124],117.17667,39.14222,{"lat":124,"lon":123},{"facility":26,"status":10,"city":127,"state":128,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":129,"geoPoint":133,"contacts":10},"Hangzhou","Zhejiang",{"type":32,"coordinates":130},[131,132],120.16142,30.29365,{"lat":132,"lon":131},{"facility":135,"status":10,"city":136,"state":128,"zip":10,"country":29,"countryCode":30,"cosmosGeoPoint":137,"geoPoint":141,"contacts":10},"Reseearch Site","Ningbo",{"type":32,"coordinates":138},[139,140],121.54945,29.87819,{"lat":140,"lon":139},{"type":10,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":143,"oldOrganization":144},"Karen Atkin\u002F VP. China R&D","AstraZeneca Pharmaceuticals","100116446","awareness-of-chinese-national-adult-lipid-treatment-guideline-2007-and-rate-of-patients-achieving-the-treatment-goal-100116446",false,"NCT00781560","Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal","A Cross-sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks","CRE NIS","Inclusion Criteria:\n\n* Diagnosed as dyslipidemia by doctors\n* Having lipids test and record within one months\n* Diagnosed as hypercholesterolemia or mixed dyslipidaemias and has been prescribed Crestor® 5mg or 10mg\n\nExclusion Criteria:\n\n* Unable or unwilling to provide the Inform Consent","ALL","18 Years",{"count":156,"type":157},2575,"ACTUAL","OBSERVATIONAL","This study is designed to survey the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists; To survey the control rate of the patients with dyslipidemia in \"real world\"; and to evaluate the percentage of hyperlipidemia patients who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007) following 8-week treatment by Crestor® 5mg or 10mg",[161],"Hyperlipidemia",[161,163,164],"Chinese National Adult Lipid Treatment Guideline (2007)","Crestor®","COMPLETED","2009-08-06",{"date":168,"type":169},"2009-08-07","ESTIMATED",{"date":171,"type":10},"2008-10",{"date":173,"type":157},"2009-07",{"name":5,"class":6},15]